Robert Kramer

2018 - Emergent BioSolutions

In 2018, Robert Kramer earned a total compensation of $2.4M as President and Chief Executive Officer at Emergent BioSolutions.

Compensation breakdown

Non-Equity Incentive Plan$538,807
Option Awards$649,980
Salary$549,047
Stock Awards$649,930
Other$8,983
Total$2,396,747

Kramer received $650K in option awards, accounting for 27% of the total pay in 2018.

Kramer also received $538.8K in non-equity incentive plan, $549K in salary, $649.9K in stock awards and $9K in other compensation.

Rankings

In 2018, Robert Kramer's compensation ranked 4,855th out of 14,244 executives tracked by ExecPay. In other words, Kramer earned more than 65.9% of executives.

ClassificationRankingPercentile
All
4,855
out of 14,244
66th
Division
Manufacturing
1,822
out of 5,765
68th
Major group
Chemicals And Allied Products
663
out of 2,128
69th
Industry group
Drugs
557
out of 1,817
69th
Industry
Pharmaceutical Preparations
431
out of 1,391
69th
Source: SEC filing on April 9, 2021.

Kramer's colleagues

We found six more compensation records of executives who worked with Robert Kramer at Emergent BioSolutions in 2018.

2018

Daniel Abdun-Nabi

Emergent BioSolutions

Chief Executive Officer

2018

Fuad El-Hibri

Emergent BioSolutions

Chairman

2018

Robert Kramer

Emergent BioSolutions

Chief Executive Officer

2018

Atul Saran

Emergent BioSolutions

General Counsel

2018

Adam Havey

Emergent BioSolutions

Executive Vice President, Business Operations

2018

Richard Lindahl

Emergent BioSolutions

Chief Financial Officer

News

You may also like